This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Chenghui Lu
Introduction
Chenghui Lu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective BCL-2 inhibitors. His work is crucial in the fight against diseases related to anti-apoptotic proteins, such as cancers.
Latest Patents
Chenghui Lu holds a patent for a crystal of a trifluoromethyl/chloro disubstituted sulfonamide selective BCL-2 inhibitor. This patent specifically relates to a crystal of a compound of formula I, a preparation method therefor, and its use in preventing and treating diseases associated with the BCL-2 protein. This innovation is particularly relevant in the context of cancer treatment.
Career Highlights
Chenghui Lu is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies against cancer.
Collaborations
Chenghui Lu collaborates with talented individuals in his field, including Huihui Zhang and Yanlong Liu. Their combined expertise contributes to the innovative environment at their workplace.
Conclusion
Chenghui Lu's contributions to the field of pharmaceuticals, particularly through his patent on selective BCL-2 inhibitors, highlight his role as an influential inventor. His ongoing work promises to enhance treatment options for cancer patients.